MedWatch

”I like it when it's complicated and difficult”

Lundbeck’s departing CEO, Kåre Schultz, has chosen to wave goodbye to the Danish pharmaceutical industry to take a job as chief executive officer of the struggling international generics manufacturer Teva. “It was an offer I couldn’t refuse,” he says.

Photo: /ritzau/Cecile Smetana/arkiv

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

FDA vil lette vejen til markedet for medicin mod Alzheimers

De amerikanske lægemiddelmyndigheder vil lempe kravene til godkendelse af lægemidler mod Alzheimers, fordi forskning viser, at sygdommen indtræder tidligere end hidtil antaget. Lægemiddeludviklingen og godkendelse heraf derfor skal tilpasses derefter, mener FDA-boss Scott Gottlieb.

Related articles